CUBICIN — Class I drug recall D-1382-2014
Terminated recall by Cubist Pharmaceuticals, Inc., reported 2014-06-18, distributed nationwide. Presence of Particulate Matter: Customer complaint stating that one vial contained a glass shard.
| Recall number | D-1382-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Cubist Pharmaceuticals, Inc., Lexington, MA, United States |
| Recall initiated | 2014-04-17 |
| Classified | 2014-06-12 |
| Reported by FDA | 2014-06-18 |
| Terminated | 2016-07-22 |
| Distributed | Nationwide (US) |
| Quantity | 51,500 vials |
| Reason classes | foreign material, specification failure |
| NDC | 67919-0011-01 |
| Lot numbers | 04/16, 280453F |
Product
CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc., Lexington, MA 02421, NDC 67919-011-01, UPC 3 67919-011-01 6.
Reason for recall
Presence of Particulate Matter: Customer complaint stating that one vial contained a glass shard.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1382-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.